Kenneth C. Anderson, MD, and Francesca M. Gay, MD, on Newly Diagnosed Multiple Myeloma: Results From the FORTE Trial

Posted: Tuesday, August 15, 2017

Kenneth C. Anderson, MD, of Dana-Farber Cancer Institute, and Francesca M. Gay, MD, of the University of Torino, discuss interim study findings on carfilzomib-lenalidomide-dexamethasone vs carfilzomib-cyclophosphamide-dexamethasone induction in newly diagnosed disease.